Industry News
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sartorius to Open New Flagship Site in Ann Arbor, MI
130,000-sq.-ft., state-of-the art plant to open in late 2023 will include product development, operations, and other support functions.09.28.21
-
Breaking News | Drug Development | Industry News
RegeneRx Licensee Acquired by Korean Biopharma Group
GtreeBNT, the licensee for several RegeneRx products, is being acquired by HLB Group, a Korean company that includes six biopharma and financial subsidiaries.09.28.21
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
Envigo, Biocytogen Enter Mouse Model Research Pact
B-NDG Triple Immunodeficient model is used in research and drug discovery in oncology, immuno-oncology, infectious disease, and stem cell biology.09.28.21
-
Breaking News | Industry News
CPhI Forecasts Record EBITDAs for CDMOs in 2022
Booster vaccines & capacity constraints during a period of high R&D investment are driving up prices for specialized facilities, advanced therapies & biologics.09.27.21
-
Breaking News | Industry News
Avantor Enters Global Distribution Agreement with Oxford Nanopore Technologies
Enables scientists to have broader access to Oxford Nanopore’s portable real-time nanopore sequencing device, MinION, associated consumables and reagents.09.27.21
-
Breaking News | Facilities | Industry News
Altasciences Expands Capacity with New Facility
Continues building expansion with additional location in Philadelphia Laval.09.27.21
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Thermo Fisher to Invest $82.5M in Manufacturing Facility Expansion
Expanded St. Louis area facility will add 169 new jobs to manufacture biologic drug substance products.09.27.21
-
Breaking News | Industry News
Vetter Achieves Climate Neutrality Across All Sites
The company’s long-term sustainability strategy pays off.09.27.21
-
Analytical Services | Breaking News | cGMP Manufacture | Industry News
Altasciences Continues Expansion with Additional Facilities in Philadelphia
Launches a second building project in Philadelphia to increase warehouse and cGMP manufacturing capacity.09.27.21
-
Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News
GRAM to Triple Capacity with $50M Investment
Phase II large-scale fill/finish expansion includes advanced modular technology and commercial-scale filling equipment.09.27.21
-
Breaking News | Industry News | Promotions & Moves
Center for Breakthrough Medicines Appoints Joerg Ahlgrimm as CEO
Mr. Ahlgrimm joined CBM in September 2020 as chief operating officer.09.24.21
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
First Customer Boards Recipharm’s Soft Mist Inhaler Technology Platform
The device platform consists of both prefilled syringe inhaler devices and clinical devices.09.24.21
-
Breaking News | Drug Delivery | Industry News | Parenterals
Owen Mumford Pharmaceutical Services Launches Aidaptus Auto-Injector Platform
Aidaptus accommodates both 1mL and 2.25 mL prefilled glass syringes in the same base device.09.23.21
-
Bio News | Breaking News | Industry News
Astrea Bioseparations Invests in Critical Infrastructure in UK and Singapore
Also appoints Dr. Claire Dacombe as vice president of Asia Pacific Operations.09.23.21
-
Bio News | Breaking News | Industry News | Process Development
Samsung Biologics Introduces S-Cellerate Platform
Offers clients an integrated and seamless drug development solution resulting in accelerated timelines.09.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CDMO List Labs Partners with Genome & Company
Creates global microbiome research, development and manufacturing powerhouse.09.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Parenterals
Arranta Bio Unveils mRNA Vaccines Manufacturing Capability
Announces first end-to-end manufacturing for mRNA vaccines in its commercial-ready GMP facility.09.23.21
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Allarity Therapeutics and Lonza to Develop and Manufacture Dovitinib
Aim to commence manufacturing of dovitinib in 2022 to meet Allarity’s projected needs for bringing dovitinib to market.09.23.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Lonza Further Invests in Drug Product Manufacturing Capabilities
New filling line to process various modalities, including monoclonal antibodies, bioconjugates, viral vectors, and other gene therapy products.09.22.21
-
Breaking News | Drug Development | Drug Discovery | Industry News
Rentschler Biopharma to Support Albert Einstein Discovery Center
Donates 50,000 Euros to support the creation of the discovery and activity center in Ulm.09.22.21
